Evidence map›Paper›PMID 36740154›Full record

ArticleEnvironmental research2023

Individual blood concentrations of persistent organic pollutants and chemical elements, and COVID-19: A prospective cohort study in Barcelona.

Miquel Porta, José Pumarega, Magda Gasull, Ruth Aguilar, Luis A Henríquez-Hernández, Xavier Basagaña, Manuel Zumbado, Judit Villar-García, Cristina Rius, Sneha Mehta and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Environmental research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Miquel PortaHospital del Mar Medical Research Institute (IMIM PSMar), Barcelona, Spain; School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain. Electronic address: mporta@imim.es.
José PumaregaHospital del Mar Medical Research Institute (IMIM PSMar), Barcelona, Spain; School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
Magda GasullHospital del Mar Medical Research Institute (IMIM PSMar), Barcelona, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain.
Ruth AguilarISGlobal - Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Luis A Henríquez-HernándezToxicology Unit, Research Institute of Biomedical and Health Sciences, Department of Clinical Sciences, Universidad de Las Palmas de Gran Canaria, Canary Islands, Spain; CIBER de Obesidad y Nutrición (CIBEROBN), Madrid, Spain.
Xavier BasagañaCIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; ISGlobal - PSMar - PRBB, Barcelona, Spain.
Manuel ZumbadoToxicology Unit, Research Institute of Biomedical and Health Sciences, Department of Clinical Sciences, Universidad de Las Palmas de Gran Canaria, Canary Islands, Spain; CIBER de Obesidad y Nutrición (CIBEROBN), Madrid, Spain.
Judit Villar-GarcíaHospital del Mar Medical Research Institute (IMIM PSMar), Barcelona, Spain.
Cristina RiusCIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; Agència de Salut Pública de Barcelona, Barcelona, Spain.
Sneha MehtaHospital del Mar Medical Research Institute (IMIM PSMar), Barcelona, Spain; Columbia Mailman School of Public Health, New York, USA.
Marta VidalISGlobal - Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Alfons JimenezISGlobal - Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Laura CampiHospital del Mar Medical Research Institute (IMIM PSMar), Barcelona, Spain; School of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Joan LopHospital del Mar Medical Research Institute (IMIM PSMar), Barcelona, Spain.
Octavio L Pérez LuzardoToxicology Unit, Research Institute of Biomedical and Health Sciences, Department of Clinical Sciences, Universidad de Las Palmas de Gran Canaria, Canary Islands, Spain; CIBER de Obesidad y Nutrición (CIBEROBN), Madrid, Spain.
Carlota DobañoISGlobal - Hospital Clínic - Universitat de Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.
Gemma MoncunillISGlobal - Hospital Clínic - Universitat de Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Barcelona, Spain.
Barcelona Institute for Global Health · ESUniversidad de Las Palmas de Gran Canaria · ESUniversitat Autònoma de Barcelona · ESUniversitat Pompeu Fabra · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESHospital del Mar Research Institute · ESHospital Del Mar · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is wide, largely unexplained heterogeneity in immunological and clinical responses to SARS-CoV-2 infection. Numerous environmental chemicals, such as persistent organic pollutants (POPs) and chemical elements (including some metals, essential trace elements, rare earth elements, and minority elements), are immunomodulatory and cause a range of adverse clinical events. There are no prospective studies on the effects of such substances on the incidence of SARS-CoV-2 infection and COVID-19.

objectiveTo investigate the influence of blood concentrations of POPs and elements measured several years before the pandemic on the development of SARS-CoV-2 infection and COVID-19 in individuals from the general population.

methodsWe conducted a prospective cohort study in 154 individuals from the general population of Barcelona. POPs and elements were measured in blood samples collected in 2016-2017. SARS-CoV-2 infection was detected by rRT-PCR in nasopharyngeal swabs and/or by antibody serology using eighteen isotype-antigen combinations measured in blood samples collected in 2020-2021. We analyzed the associations between concentrations of the contaminants and SARS-CoV-2 infection and development of COVID-19, taking into account personal habits and living conditions during the pandemic.

resultsSeveral historically prevalent POPs, as well as arsenic, cadmium, mercury, and zinc, were not associated with COVID-19, nor with SARS-CoV-2 infection. However, DDE (adjusted OR = 5.0 [95% CI: 1.2-21]), lead (3.9 [1.0-15]), thallium (3.4 [1.0-11]), and ruthenium (5.0 [1.8-14]) were associated with COVID-19, as were tantalum, benzo(b)fluoranthene, DDD, and manganese. Thallium (3.8 [1.6-8.9]), and ruthenium (2.9 [1.3-6.7]) were associated with SARS-CoV-2 infection, and so were lead, gold, and (protectively) iron and selenium. We identified mixtures of up to five substances from several chemical groups, with all substances independently associated to the outcomes.

conclusionsOur results provide the first prospective and population-based evidence of an association between individual concentrations of some contaminants and COVID-19 and SARS-CoV-2 infection. POPs and elements may contribute to explain the heterogeneity in the development of SARS-CoV-2 infection and COVID-19 in the general population. If the associations are confirmed as causal, means are available to mitigate the corresponding risks.

Indexed as

COVID-19Environmental PollutantsRutheniumHumansPersistent Organic PollutantsProspective StudiesSARS-CoV-2ThalliumEnvironmental PollutantsPersistent Organic PollutantsRutheniumThalliumCOVID-19Environmental pollutantsImmunotoxicityMetalsSARS-CoV-2

Identifiers

PMID36740154
PMCPMC9898057
OpenAlexW4319165512

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.